Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status

Background: While cerebral beta-amyloid accumulation was found in many studies to alter precuneus-based functional connectivity (FC) in mild cognitive impairment and demented Alzheimer’s disease (AD) patients, its impact is less well understood in subjective cognitive decline (SCD), which in the presence of underlying AD pathologic change corresponds to a progression to stage 2 of the clinical Alzheimer’s continuum in the 2018 National Institute on Aging and Alzheimer’s Association research framework, and represents the earliest clinical manifestation of AD. Methods: From the DELCODE (DZNE – Longitudinal Cognitive Impairment and Dementia Study) cohort, two groups of 24 age- and gender-matched amyloid-positive SCD (SCD Aβ+ ) and amyloid-negative SCD (SCD Aβ- ) patients were selected according to visual [18F]-Florbetaben PET readings, and studied with resting-state BOLD fMRI. Local (regional homogeneity (ReHo), amplitude of low-frequency fluctuation (ALFF) and fractional ALFF (fALFF)) and global (degree centrality (DC), precuneus seed-based FC maps) measures were calculated and compared between both groups. Furthermore, follow-up correlation analyses probed linear relationships of observed group differences with global as well as precuneal amyloid load measured by Florbetaben standard uptake value ratios (SUVR FBB ). Results: For the local measures, ReHo was significantly higher in the bilateral precuneus for the SCD Aβ + group, whereas ALFF and fALFF measures were not altered between groups. For the global measures, relatively higher precuneus-based FC with occipital areas (but no altered DC) was observed in the SCD Aβ+ group. Moreover, the FC differences between precuneus and occipital areas were positively correlated with global (SCD Aβ+ ) and local precuneus SUVR FBB (both groups). Conclusions: While confounding influences due to a higher ratio of APOE e4 carriers in the SCD Aβ+ group cannot be excluded, results indicate functional alterations in the precuneus hub region that were linearly related to beta-amyloid load, highlighting incipient

(SCD Aβ-) patients were selected according to visual [18F]-Florbetaben PET readings, and studied with resting-state BOLD fMRI. Local (regional homogeneity (ReHo), amplitude of low-frequency fluctuation (ALFF) and fractional ALFF (fALFF)) and global (degree centrality (DC), precuneus seed-based FC maps) measures were calculated and compared between both groups. Furthermore, follow-up correlation analyses probed linear relationships of observed group differences with global as well as precuneal amyloid load measured by Florbetaben standard uptake value ratios (SUVR FBB ).
Results: For the local measures, ReHo was significantly higher in the bilateral precuneus for the SCD Aβ + group, whereas ALFF and fALFF measures were not altered between groups. For the global measures, relatively higher precuneus-based FC with occipital areas (but no altered DC) was observed in the SCD Aβ+ group. Moreover, the FC differences between precuneus and occipital areas were positively correlated with global (SCD Aβ+ ) and local precuneus SUVR FBB (both groups).
Conclusions: While confounding influences due to a higher ratio of APOE e4 carriers in the SCD Aβ+ group cannot be excluded, results indicate functional alterations in the precuneus hub region that were linearly related to beta-amyloid load, highlighting incipient pathology and possible compensatory mechanisms in stage 2 of the AD continuum.

Background
Subjective cognitive decline (SCD) is increasingly acknowledged as the earliest symptomatic manifestation of Alzheimer's disease (AD) (1, 2). According to the conceptual framework for SCD research, subjective complaints include 'self-experienced persistent decline in cognitive capacity in comparison with a previously normal status and unrelated to an acute event', along with 'normal age-, gender-, and education-adjusted performance on standardized cognitive tests, which are used to classify mild cognitive impairment (MCI) or prodromal AD' (2). Although SCD is not specific for the presence of underlying AD pathology, an increased prevalence of preclinical AD cases has been reported in SCD complainers (3)(4)(5), providing support in favor of using the SCD concept as 'enrichment strategy' for preclinical AD studies (2). Individuals with SCD and existing biomarker evidence for AD pathology were shown to be at increased risk of future cognitive decline, progression to MCI and, ultimately AD dementia (6)(7)(8)(9)(10). SCD with biomarker evidence of underlying AD pathologic change corresponds to stage 2 of the clinical AD continuum according to the novel NIA-AA (National Institute on Aging and Alzheimer's Association) working group criteria (11). According to recent metaanalytical evidence (12), available biomarker evidence for AD in combination with subtle cognitive decline is associated with an increased risk of clinical progression (73%), compared to asymptomatic amyloidosis alone (20%).
Brain functional alterations can be determined by functional connectivity (FC) analyses using restingstate functional magnetic resonance imaging (rs-fMRI), which is a sensitive tool for interrogating intrinsic functional connectivity properties and determining functional network disruptions as a consequence of underlying AD pathology. Functional connectivity alterations have been demonstrated in manifest AD dementia (13)(14)(15)(16) and MCI (13,(17)(18)(19). Pertinent findings have been summed up in reviews and meta-analytical analyses (20)(21)(22), reporting AD stage-dependent FC alterations mainly in regions within default mode network (DMN), salience, and limbic networks (20,23,24). In the manifest AD stage, local [11C]-PiB (Pittsburgh Compound B) uptake in positron emission tomography (PET) correlates negatively with DMN connectivity (25), providing a direct link between amyloid load as a core pathological feature of AD and downstream functional readouts, although controversial findings were also reported (26). Amyloid load measured with PET in AD dementia /MCI is also linked with the fractional amplitude of low frequency fluctuation (fALFF), a marker for the strength / intensity of slow fluctuations in resting brain activity (26).
There is growing evidence that FC alterations already emerge during the preclinical stages of AD, and are linked with brain amyloid accumulation: The involvement of DMN structures is of special interest here, as its hub regions like the posterior cingulate cortex (PCC)/ precuneus appear particularly vulnerable to amyloid accumulation, and are among the first brain structures that show increasing amyloid tracer uptake in early amyloidosis (27). Various studies have described reductions of DMN connectivity in cognitively normal elderly with significant amyloid plaque depositions (28)(29)(30). Only subtle FC disruptions were observed in amyloid-positive asymptomatic older individuals by Drzezga et al. (31), whereas amyloid-positive MCI showed significant disruptions of whole-brain FC in 'typical cortical hubs' like the PCC/precuneus, suggesting incipient functional deterioration. Meanwhile, there are also studies showing FC increases (32), or mixed patterns of FC increases and decreases (33), which may represent functional shifts within and between FC networks that are related to amyloid accumulations (34).
Building on the assumption that SCD patients are at-risk for preclinical AD, a variety of studies started to explore whether AD-related patterns of FC alterations (especially in DMN areas) are already observable here (35)(36)(37)(38)(39) (43) in asymptomatic subjects with a family history of AD described increased FC between the posterior DMN and medial temporal areas in individuals with SCD, as compared to non-complainers. In contrast, Viviano et al. (44) observed reduced average connectivity among posterior (especially between precuneus and retrosplenial cortex), but not among anterior memory system nodes. Chiesa et al. (45) analyzed longitudinal DMN connectivity changes over 24 months, and observed widespread FC increases (along with limited decreases in dorsal aspects of the precuneus) within a large cohort of SCD individuals.
To some degree, the variability of available FC finding may relate to the fact that most of these studies examined SCD patients without stratifying by AD biomarker status, i.e. actual FC changes related to preclinical AD pathology in SCD populations may be obscured by varying proportions of participants with SCD due to non-AD mechanisms. For example, Yasuno et al. (41) reported that among 13 SCD participants who performed amyloid PET, only one was classified amyloid-positive (but see: (45)). Likewise, there is very limited data examining possible correlations between amyloid biomarkers and FC measures in SCD populations directly: While Yasuno et al. (41)  Here, we report data from DELCODE (DZNE -Longitudinal Cognitive Impairment and Dementia Study), which is an ongoing observational longitudinal multicenter study focusing on SCD (47).
Considering (i) that most of the abovementioned studies were not specifically targeted on SCD as early clinical manifestation of possible AD, (ii) that few studies in the SCD stage were informed by amyloid biomarker status, and (iii) that the precuneus is an important hub region of the posterior DMN showing a high vulnerability for amyloid depositions (48,49), this study specifically addressed the question how amyloid pathology relates to several local and global measures of rs-fMRI in SCD patients exclusively recruited from memory clinics. The focus of this study is on the precuneus. While an initial analysis from this cohort (18) found no FC alterations that differentiated SCD from healthy controls, this preliminary subsample did not include enough SCD with proven amyloid pathology (SCD Ab+ , as measured by cerebrospinal fluid [CSF]) to systematically examine specific alterations in this subgroup, as compared to healthy controls, or SCD without amyloid pathology (SCD Ab-). Here, we used qualitative ratings from amyloid PET examinations to directly compare 24 SCD Ab+ with 24 ageand sex-matched SCD Ab-participants (see also: (42)). We hypothesized (i) precuneus-based FC changes and alterations of regional measures to occur in SCD Ab+ , as compared to SCD Ab-, and (ii) these changes to correlate with the severity of global and regional precuneus Aβ load which we examined in additional, exploratory analyses. The direction of respective changes was not predicted a priori, based on equivocal findings in the available literature in SCD patients.

General procedures
All participants in this study were taken from the PET sub-cohort of the DELCODE study, whose overall study design and detailed inclusion and exclusion criteria have been described elsewhere (47). PET scans, the first 24 SCD Ab+ individuals with significant cerebral amyloid depositions and valid rs-fMRI data were compared with a respective group of 24 age-and sex-matched SCD Ab-participants without significant cerebral amyloid depositions.

Sample characteristics
Further details about sample characterization can be found elsewhere (47). In brief, all DELCODE study participants complete extensive neuropsychological testing during the yearly study visits, including the Mini Mental State Examination (MMSE: (50)), and a modified version of the Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-13: (51)). Apolipoprotein (APOE) genotyping was performed using commercially available TaqMan® SNP Genotyping Assay (ThermoFisher Scientific).
[18F]-Florbetaben PET acquisition PET data were acquired on clinical PET/CT or PET/MR scanners at the nuclear medicine departments of the participating sites (Table S1). Data acquisition followed established standard procedures for FBB scanning: After intravenous FBB tracer application of 282 ± 9 MBq, dynamic 3D-acquisition of list mode emission data started 90.9 ± 3.6 min post-injection, for a total duration of 20 minutes (which were subsequently reconstructed into 4 x 5 min time frames). Additionally, low-dose CT (or for PET/MR: 3D Dixon-VIBE sequences) were collected for calculation of attenuation correction maps.
Iterative reconstruction was performed based on the established PET brain protocols at the local sites, including decay, random, scatter, dead time, normalization, and attenuation correction.
[18F]-Florbetaben PET analyses Qualitative analysis: As the current gold-standard, visual readings of the [18F]-Florbetaben (FBB) scans were conducted by two experienced readers (HB, FG) according to manufacturer guidelines (52), resulting in a consensus rating of amyloid positivity (SCD Ab+ ) and amyloid negativity (SCD Ab-) which was used for group definition.
Quantitative analysis: To explore potential linear relationships between the severity of cortical amyloid load and rs-fMRI measures, we conducted secondary quantitative analyses. Using the PNEURO Maximum Probability Atlas pipeline in PMOD 4.004 (PMOD Technologies LLC, Zurich, Switzerland), PET images series were motion-corrected and coregistered with a T1-weighted anatomical scan of the participant (see below) which was segmented using Unified Segmentation (53). Normalization parameters from this segmentation were used to warp the AAL atlas template were averaged across voxels and time frames. Similar to Barthel et al. (55), a volume-weighted average of bilateral frontal, lateral temporal, parietal, occipital and cingulate SUV was calculated, and scaled by tracer uptake in the cerebellar cortex to derive a global SUV ratio (SUVR FBB ) for measuring global Aβ load. The same procedure was applied to left and right precuneus VOI to derive regional SUVR FBB for the bilateral precuneus.

MRI acquisition
MRI data acquisition was performed on 3 Tesla Siemens scanners from seven scanning sites across Germany, using harmonized imaging sequences across sites. The rs-FMRI data were acquired axially using an echo-planar imaging (EPI) sequence with the following sequence parameters: TR/TE = 2580/

rs-fMRI data preprocessing
The rs-fMRI data preprocessing steps were conducted using the Data Processing & Analysis for Brain Imaging (DPABI) toolbox (56) in Matlab 2015a (MathWorks, Inc., Natick, MA). The first 5 EPI volumes were discarded to account for transient signal changes before magnetization reached a steady-state.
The remaining 175 EPI volumes were corrected for different signal acquisition times and head movements. The T1-weighted images were co-registered to the mean of the realigned functional images series, and segmented into GM, WM and CSF (53). Nuisance covariates including 24 motion parameters (57), white matter and CSF mean time course signals were regressed out. In addition, a motion scrubbing regressor method (58) was used for each bad time point (frame-wise displacement > 0.2 mm included as covariate). The images were normalized into ICBM-152 reference space using DARTEL (Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra: (59)). According to previous studies, spatial smoothing was performed with a Gaussian kernel of 6 mm full-width at half-maximum (FWHM) before ALFF, fALFF and FC calculation (60), but after ReHo and degree centrality (DC) calculation (61). Finally, temporal band-pass filtering (0.01-0.08 Hz) was adopted to reduce the effect of low-frequency drifts and high-frequency physiological noise before ReHo and DC calculation, but after ALFF and fALFF calculation.

Regional Homogeneity (ReHo) calculation
ReHo represents a voxel-based measure of brain activity which evaluates the local synchronization between the time series of a given voxel and its nearest neighbors (62). We used DPABI to obtain each subject's ReHo map by calculating Kendall's coefficient of concordance for a given voxel time series with its nearest 26 neighboring voxels. This analysis was based on the unsmoothed preprocessed images (62). To improve comparability between subjects, standard normal z transformation was applied to all ReHo maps. Finally, these 'zReHo maps' were spatially smoothed with a 6 mm FWHM Gaussian kernel for the following statistical analysis.
Amplitude of Low Frequency (ALFF) and fractional ALFF calculation ALFF is defined as the total power within the low frequency range (0.01-0.08 Hz) and represents the strength or intensity of low frequency oscillations (LFO), while fALFF is defined as the power within the low-frequency range divided by the total power in the entire detectable frequency range and represents the relative contribution of specific LFO to the whole frequency range (63). Individual ALFF maps were calculated using DPABI, as described previously (64). The functional time series of each voxel was transformed to the frequency domain using a fast Fourier transform algorithm and the power spectrum was obtained. As the power of a given frequency is proportional to the square of the amplitude of this frequency component, the square root was calculated at each frequency of the power spectrum and the averaged square root was obtained across 0.01-0.08 Hz at each voxel. This averaged square root was taken as the ALFF value (64). Moreover, fALFF was calculated using the ratio of power spectrum of low-frequency (0.01 Hz to 0.08 Hz) to that of the entire frequency range.
For statistical analysis, standard normal z-transformation was applied to all ALFF and fALFF maps (to generate the zALFF and zfALFF maps).
Degree Centrality (DC) calculation DC represents the number of direct connections for a given voxel in voxel-based graphs (65) and has been widely used to represent the node property of large-scale brain networks. DC maps were calculated as described previously (66) using DPABI. Specifically, we calculated Pearson's correlations between the time course of any pair of voxels within the whole brain to generate the functional connectivity matrix. We obtained each subject's undirected adjacency matrix by thresholding each correlation at r > 0.25, in order to exclude voxels that had low temporal correlation attributable to signal noise (65). Standard normal z transformation was applied to each DC map to generate the zDC map. Finally, the zDC maps were spatially smoothed with a 6 mm FWHM Gaussian kernel for the following statistical analysis.

Voxel-based Bilateral Precuneus FC Analysis
FC analysis of the bilateral precuneus was conducted in voxel-wise manner. The seed region, bilateral precuneus, was generated from the AAL atlas, multiplied with the GM mask. Voxel-wise FC map was calculated using the correlations between the mean time series of the seed region and remaining voxels within the brain. To improve the normality of FC correlation coefficient maps, the correlation coefficients were converted to z values using Fisher's transformation.

Sample characteristics and Amyloid SUVRs
Descriptive statistics of background characteristics for the SCD Aβ+ and SCD Aβ-samples are presented in Table 1, showing no significant group differences, except for a higher proportion of APOE e4 carriers in the SCD Aβ+ . As expected, the global SUVR FBB and the regional precuneus SUVR FBB was significantly higher in the SCD Aβ+ compared to the SCD Aβ-group. Yet, we note that several participants in both subgroups showed global SUVR values borderline to previous FBB SUVR cut-off definitions for amyloid positivity, resulting in slightly varying amyloid-positivity classifications. Using N=5 SCD Aβ-would be classified amyloid-positive.

Group comparison: Local rs-fMRI metrics
The voxel-based ReHo analysis revealed significantly increased ReHo in the bilateral precuneus and the adjacent superior parietal lobule in the SCD Aβ+ , as compared to the SCD Aβ-group (Table 2, Figure   1). On the other hand, no significant group differences were found in ALFF/ fALFF and in DC.

Group comparison: Global rs-fMRI metrics
Voxel-wise FC analysis revealed that the SCD Aβ+ group showed an increased FC between the precuneus mean time course and occipital regions, including the superior occipital gyrus and the bilateral cuneus (Table 3, Figure 2).

Possible influence of nuisance variables:
To test for possible effects of (a) different MR sites on rs-fMRI measures in this multi-center study and (b) the highly significant group differences in APOE genotype, additional second-level two-sample ttests with MR scanners (dummy-coded) and APOE status (e4+/e4-) as additional covariates were performed. For ReHo, these analyses yielded slightly weaker findings (likely due to the reduced degrees of freedom), but left-sided group differences were still significant ( Figure S1), indicating that pertinent findings were not primarily influenced by scanner effects or APOE status. As for the precuneus-FC findings, this analysis rendered the reported group differences nonsignificant, suggesting that confounding influence of APOE genotype cannot be excluded, as significant group differences were still evident in a separate model controlling for MR scanners only ( Figure S2).

Exploratory analyses: Associations of FC differences with quantitative amyloid load
No significant association was found between the global and/or local precuneus SUVR FBB and the mean z-score of the ReHo extracted from the precuneus cluster that showed the significant group difference between the SCD Aβ+ and SCD Aβ-groups.

Discussion
Our study, focusing on the SCD sub-cohort of DELCODE explored precuneus-based whole-brain FC and several regional and global measures of rs-fMRI changes in matched SCD Aβ+ compared to the SCD Aβgroups. Additionally, we studied the relationship between the rs-fMRI measures and global/ precuneus Aβ load. The key findings were a demonstration of increased ReHo in bilateral precuneus and adjacent superior parietal gyrus in the SCD Aβ+ group, as compared to the SCD Aβ-group (Figure 1), but no significant difference regarding ALFF / fALFF and DC measures. Moreover, SCD Aβ+, as compared to SCD Aβ-participants, were characterized by increased precuneus FC with occipital regions (Figure 2).
While confounding influences of group differences regarding APOE genotype cannot be excluded, the additional observation ( Figure 3) that FC increases between precuneus and occipital areas showed positive linear associations with global (SCD Aβ+ ) as well as local precuneus amyloid load (SCD Aβ+ and SCD Aβ-) argues for gradual connectivity changes that are partially related to incipient accumulation of amyloid pathology.
Several previous studies have shown associations of Aβ accumulation not only with decreased, but also with increased connectivity in nondemented populations (32,33). However, as yet the functional consequences resulting from elevated amyloid burden in the SCD stage remain unsolved. The precuneus was of particular interest for this study as this region is known to be vulnerable for early Aβ deposition (67), with higher Aβ deposition being found in both, AD (65) and MCI (68). A recent study in elderly healthy controls, SCD and MCI patients provided further proof that Aβ accumulation preferentially starts in the precuneus, along with medial orbitofrontal, and PCC (27).
Our results showed increased bilateral precuneus FC with adjacent occipital areas in SCD Aβ+ , which is partially consistent with a study (30) observing stronger precuneus-occipital connectivity in Aβ+ (as compared to Aβ-) cognitively normal participants. There are also parallels with previous work (40) using independent component analysis (ICA) with dual regression to investigate resting-state FC: Compared with age-matched controls, patients with subjective memory complaints showed increased FC within the DMN and medial visual network. Unfortunately, these group comparisons were not informed by amyloid biomarker information. In a recent paper investigating individuals with a family history of AD (43), increased FC of the posterior DMN (PCC) with the medial temporal memory system was found in participants who were complaining about SCD (as compared to non-complainers). Yet, SCD classification was only based on a single questionnaire item examining subjective worsening of memory, and AD pathology was not scrutinized by AD biomarkers. Interestingly, previous studies in cognitively normal individuals also reported posterior DMN hyperconnectivity to be correlated with AD risk factors and, hence, could represent an early compensatory mechanism to overcome cognitive decline (32,(69)(70)(71). These findings are supported and further extended by the current study: The observed higher connectivity of the precuneus with the occipital gyrus, qualified by the positive association between FC in occipital regions and regional precuneus Aβ load may indeed reflect a local compensatory mechanism at an early pathophysiological stage that helps to maintain normal behavioral performance in SCD Aβ+ . In this context, a recent publication by Schultz  Interestingly, the positive association between precuneus-occipital FC and global SUVR FBB values was only visible in the SCD Aβ+ subgroup, while a positive correlation with the precuneus SUVR FBB also emerged in the SCD Aβ-subgroup. This may indicate that these FC changes are mainly driven by incipient local (=precuneus) amyloid accumulations which are masked in global composites.
Complementary evidence for regional specificity comes from a mixed population of SCD and healthy controls (73) who had negative amyloid PET scans (according to visual reading and global cortical SUVR cut-offs) but showed positive correlations between dynamic whole-brain connectivity measures and SUVR values from brain areas with early amyloid accumulation (including PCC and precuneus: see (48)). These relationships were not evident when using complementary SUVR values from an entire DMN, or global cortical mask.
No significant differences between SCD Aβ+ and SCD Aβ-were found for the ALFF/fALFF and DC measures. Although both, ReHo and ALFF/fALFF measures reflect brain regional spontaneous neuronal activity, there are considerable differences with ReHo which reflects similarity of spontaneous neuronal activity among nearby voxels. Therefore, our results may suggest ReHo to be a more sensitive measure for detecting early local brain activity alterations interpreted as a functional compensation mechanism for enhancing regional coherence of neuronal activity. Our non-significant results regarding DC, which is a measure based on graph theory, may indicate that brain function at the network level is still not altered in the SCD Aβ+ group, as compared to the SCD Aβ-group.
The observation of higher precuneal ReHo and FC in SCD Aβ+, compared to SCD Aβ-, may correspond to elevated compensation in a very early stage of preclinical AD (33,40,43) where additional neuronal processing is required to balance the brain workload, thereby, maintaining normal cognitive functioning. Yet, in a mechanistic sense, Aβ pathology may also be accelerated by increased metabolism and elevated intrinsic activity / connectivity (31,74,75), with laboratory evidence indicating that neuronal activity directly increases production of Aβ peptides (76). Considering that the precuneus is a prominent 'hub' in the intrinsic FC matrix of the human brain and metabolically active (77), our finding of relatively higher connectivity and ReHo within this region might indeed trigger (or amplify) Aβ production in SCD Aβ+.
Due the significantly higher rate of APOE e4 carriers in the amyloid-positive group, which is not unexpected given the frequently observed association between APOE genotype and amyloidosis (78), it is difficult to disentangle the relative contributions of amyloid positivity per se and APOE genotype, to FC group differences. While left-sided ReHo group differences survived even after controlling for APOE status (Figure S1), precuneal-FC group differences were rendered non-significant. The available sample size precluded further stratifications according to APOE status. While APOE genotype was shown to have independent effects on FC measures, even in individuals whose amyloid PET was negative (34,69,79), its influence may also be indirectly mediated by its effect on amyloid accumulation. Actually, the observed linear association between quantitative amyloid load, especially in the precuneus, and precuneal FC with the occipital region (Figure 3), would support the latter interpretation. Therefore, further studies will have to be awaited to further explore the FC changes in SCD with complementary amyloid and tau biomarker information.

Conclusions
In summary, our study in well-matched SCD cohorts differing in PET-proven cerebral amyloid Resting-state FC appears to be a useful neuroimaging biomarker for highlighting early brain functional consequences of AD pathology.

Declarations
Ethics approval and consent to participation:

Consent for publication:
Not applicable

Availability of data and materials:
The data which support this study are not publicly available, but may be provided upon reasonable request.

Competing interests:
KB is advisor for Biogen GmbH. The other authors report no conflicts of interest relevant for this study.

Funding:
The study was funded by the German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen, DZNE), Reference number BN012.
The analyses of the Florbetaben PET exams reported in this study are subject of a research agreement with Life Molecular Imaging.

Authors' contributions:
The following authors contributed to the overall design and implementation of DELCODE      Positive correlations between increased precuneus FC with occipital regions and global SUVRFBB and precuneus SUVRFBB The grey regions are 95% confidential intervals. The mean Z-Score of the FC was extracted from significant cluster within the red circle.

Supplementary Files
This is a list of supplementary files associated with this preprint. Click to download.